The great olfactory convergence: why so many perfumes smell alike, 2015 to 2026

The paradox of infinite choice

There have never been so many perfumes. Niche houses number in the hundreds, launches follow one another without pause, and online databases record thousands of new references every year. And yet the same sentence comes back everywhere, on forums, in shops, in the messages we receive: everything ends up smelling the same. That sense of having smelled it before has become the most common experience of anyone walking into a niche aisle in 2026.

This is not an illusion, nor simple collector fatigue. Since the middle of the 2010s, a handful of synthetic molecules has structured the majority of contemporary compositions, in niche perfumery as much as at the large brands. They are neither new nor fraudulent: they are old, robust, inexpensive materials whose patents have expired, and which perfumery has turned into a shared language. The result is a family of trails that share the same skeleton.

This article follows that thread in five stages. First the molecules themselves: where they come from, what they do, why they are everywhere. Then the economic model that imposes them, which matters more than the taste of any individual perfumer. Then perception, meaning the way the public has learned to name this uniformity. Finally the houses that step aside from it, and the signals, in 2025 and 2026, suggesting the cycle may be turning. We write this as curious technicians rather than prosecutors: convergence can be explained, and what can be explained can be worked around.

The molecules that turn up everywhere

Five synthetic materials recur with striking regularity across the compositions of the decade. None of them is recent: the youngest dates from 1973, the oldest from 1950. What changed after 2015 is not their existence but their dosage, their openly assumed visibility, and the way they accumulate in a single formula. Each solves a precise technical problem, which is exactly why each became a reflex.

Ambroxan, mineral light turned reflex

Ambroxan was developed in 1950 at Firmenich in Geneva by the chemists Max Stoll and Martin Hinder, under the scientific direction of Leopold Ruzicka, Nobel laureate in chemistry in 1939. The patented route starts from sclareol, a diterpene extracted from clary sage, converted into sclareolide and then cyclized into ambroxide. The molecule reproduces the principal odorous compound of ambergris, whose trade closed for good in 1981 when the sperm whale was listed in CITES Appendix I.

Its profile is ambery woody musky mineral, dry, faintly salty, with a clean skin effect and an extremely low perception threshold. For thirty years it served as a discreet fixative. The turning point was artistic before it was commercial: in 2008, Geza Schoen composed Molecule 02 at one hundred percent Ambroxan, a gesture with no equivalent in commercial perfumery. Then came 2014 and 2015, with Baccarat Rouge 540 by Francis Kurkdjian, commissioned for the two hundred and fiftieth anniversary of the Baccarat crystal works, and Sauvage by Dior, signed by Francois Demachy. Two global successes built on the same ambery light. Since then Ambroxan has appeared in a very large majority of fine fragrance launches, at dosages that no longer try to hide.

Iso E Super, the halo you cannot see

Synthesized in 1973 in the IFF laboratories in New York by John B. Hall and James M. Sanders, patented in 1975, Iso E Super remained captive to that house until around 2000. The lapse of the patent is the real starting point of its spread: what had been one manufacturer's internal signature became available to the entire profession.

Its profile is ambery woody velvety, transparent, faintly musky. Blind, you recognize it less by a smell than by an effect: a halo that settles around the skin, and a tenacity that often exceeds twelve hours. It carries a rare peculiarity, a partial anosmia affecting twenty to twenty-five percent of the population, a phenomenon documented since the work of Linda Buck and Richard Axel on olfactory receptors. In 2006, Molecule 01 by Escentric Molecules turned it into a manifesto. Its price, forty to ninety euros per kilogram in 2026, makes it one of the most affordable molecules in the trade. Cheap, unrestricted, off patent: the perfect triptych for generalization.

Cashmeran, the comfort that rounds everything off

Developed by IFF in 1970, Cashmeran takes its name from the tactile sensation of cashmere: softness, warmth, envelopment. Its profile is warm velvety woody, musky powdery, faintly ambery and dry fruity, with powerful fixative strength. It is commonly used between two and fifteen percent of a formula, sometimes up to twenty-five in ambery woody compositions.

Several perfumers reach for it where they would once have used Iso E Super, when they want a rounder signature and less of the dry woody transparency. That substitution explains its ubiquity: it delivers, immediately, the comfort a public raised on gourmands and ambers expects. Tobacco Vanille by Tom Ford in 2007, Aventus by Creed in 2010, Spicebomb by Viktor & Rolf in 2012 and Black Opium by Yves Saint Laurent in 2014 fixed the grammar that niche perfumery then adopted as its own.

Ethyl maltol, the burnt sugar in every gourmand

Discovered in 1963, ethyl maltol, chemically 2-ethyl-3-hydroxy-4H-pyran-4-one, is markedly more powerful than the maltol it derives from. Its odor is immediately identifiable: caramel, burnt sugar, cotton candy. It does not exist in nature.

Its breakthrough with the general public can be dated to the day: Angel by Thierry Mugler, composed by Olivier Cresp in 1992, founded the modern gourmand family on that axis. Thirty years later, niche perfumery has taken the formula back, in the current the market calls dark gourmand. The effect cuts both ways: ethyl maltol yields a signature recognizable within seconds, but it imposes itself on the entire composition. A gourmand that overuses it no longer smells of the vanilla, tonka bean or cocoa it claims to be telling. It smells of ethyl maltol.

Hedione, invisible transparency

Synthesized at Firmenich by Edouard Demole from 1958 onward and patented in 1962, Hedione is a methyl dihydrojasmonate inspired by one facet of natural jasmine. Its profile is transparent jasmine floral, luminous, almost watery. Its job is not to last but to fluidify: it opens up the olfactory space of a composition.

Roudnitska made it the axis of Eau Sauvage in 1966, the first use at high dosage. Since then it has moved from discovery to infrastructure. It commonly occupies ten to twenty percent of a commercial formula, and up to thirty or fifty percent in the most transparent contemporary writing. Nobody names it in a pyramid, and almost everyone smells it: it is the most invisible and the most universal molecule on this list.

Five molecules, five reasons to be everywhere

The economic model that pushes toward convergence

Convergence is not, in the first instance, a matter of taste. It is a predictable consequence of how the composition industry makes and protects its materials. Understanding that mechanism makes the whole scene far less mysterious.

A new molecule is born captive. The manufacturer that discovers it patents it and reserves its use, generally for twenty years. The investment is heavy: the order of magnitude reported within the trade places the development of a captive between five and fifteen million euros and between five and ten years of research, in a sector that devotes seven to nine percent of revenue to research. Of the thousands of molecules screened each year, fewer than ten, according to practitioners, make it to commercial launch.

The filter runs on four criteria: the synthesis must be industrializable, the smell must convince the evaluators, the cost must remain compatible with formulas sold by the kilo, and the safety dossier must clear. That filter eliminates atypical materials by construction: a molecule that divides evaluators will not ship, even if three brilliant perfumers find it fascinating.

The free palette, the real cause of uniformity

Then comes the central paradox. The omnipresent molecules of 2026 are precisely the ones whose patents have expired. Iso E Super, Ambroxan, Hedione, Cashmeran, Galaxolide: all free, all produced by several suppliers including Chinese ones since the 2010s, none of them severely restricted by IFRA. An independent perfumer with no captive budget therefore works from exactly the same effective palette as a colleague inside a major house. That is excellent news for access to creation, and the mechanical cause of convergence.

Add the commercial pull. Baccarat Rouge 540 is probably the most imitated perfume of the decade, to the point that an entire dupe economy has organized itself around it. Every success on that scale sends the same signal to marketing departments: the market validates this olfactory direction. The next briefs ask for it, perfumers deliver it, and the loop closes. This is not creative laziness. It is an incentive system that rewards resemblance.

The perception of sameness

The most interesting cultural fact of the period is not convergence itself. It is that the public has learned to name it. Fifteen years ago, an enthusiast described a modern trail through materials: sandalwood, patchouli, vanilla. In 2026 they describe it through molecules. Phrases such as that smells of ambroxan or that smells like BR540 circulate in shop conversation and PerfumeTok videos as olfactory categories in their own right. A chemist's vocabulary has entered ordinary speech.

That new clarity has a downside. Once you can name Ambroxan you can no longer unhear it, and a perfume that uses it with finesse takes the same beating as one that clubs you with it. Specialist criticism has theorized the fatigue under the name of the Ambroxan and Iso E Super plateau of contemporary trails, a formula found notably at Persolaise and Bois de Jasmin.

A genuine physiological phenomenon compounds it. Repeated exposure to a material raises the perception threshold: a generation breathing Ambroxan every day, in perfumes as much as in laundry products, ends up needing more of it to feel anything. Overdosing answers a saturation it created itself. And for the twenty to twenty-five percent of the public partially anosmic to Iso E Super, a share of these compositions simply stays silent.

None of this is unprecedented. Perfumery in the 1990s went through exactly the same rush with Calone, a molecule developed by Pfizer in 1966 that stayed confidential until New West by Aramis in 1988 and then L'Eau d'Issey in 1992. For fifteen years everything smelled of marine melon, until the public turned away. Convergence is therefore not a disease of contemporary niche perfumery. It is a normal regime of industrial perfumery, which alternates between saturation and reaction.

The houses that refuse to converge

A few houses compose against the current. They share neither an aesthetic nor a doctrine, but one accepted constraint: giving up the most effective palette in order to keep a recognizable voice.

These houses pay a real price. Their perfumes read as less modern, because modern now means, to the public ear, transparent ambery woody. Their distribution stays confidential, their batches sell out within hours, and their price per milliliter often exceeds that of the major houses. One caricature is worth avoiding: escaping convergence does not mean banning synthetics. Andy Tauer, a chemist, is the best demonstration of that. The difference lies in the use, not in the nature of the material.

A way out? The signals of 2025 and 2026

Several movements, independent of one another, suggest the plateau could shift. None is sufficient on its own, and one of them could reproduce the problem in another form.

The return of skin scents. The aesthetic of withdrawal, minimal trail and second-skin effect, spread in the wake of quiet luxury. It is a direct reaction to the invasive trails of the previous decade. The irony is that Iso E Super is one of the materials that produce that skin effect best. The reaction sometimes runs through the same molecules, used differently.

Biotech, promise and risk. On 30 October 2019 Givaudan presented a fermentation route from sugar cane to produce its Ambrofix, claiming a hundred times less land than traditional production for identical olfactive qualities. IFF has marketed a cell-based ambergris under the Lochbridge name since the same period, and Firmenich has industrialized a biotech version of its ambery range. These processes settle a real environmental question. They do not settle convergence: producing the same molecule differently changes nothing about the smell. Biotech will move the lines only on the day it opens access to materials unreachable by classical chemistry.

The opening of the captive market. This is the year's most concrete signal. On 23 June 2026, at the World Perfumery Congress in Monterey, the American company Osmo, founded by Alex Wiltschko, launched an auction of ten proprietary molecules developed with artificial intelligence, out of the forty-three produced over three years of research, with a twelve-week evaluation period open to composition houses, brands and chemical manufacturers. If that model takes hold, it cracks the large manufacturers' monopoly on new materials and makes a captive accessible, for the first time, to someone who is not one of the seven giants.

The revival of absolute naturals. Finally, one fringe of niche perfumery is betting on traceability and on materials impossible to standardize. An oud distilled batch by batch never smells the same twice, which is an industrial defect and a guarantee of singularity. The segment remains tiny and expensive, but it occupies exactly the space convergence has vacated.

Our reading, in August 2026: the way out will not come from any moral renunciation by the houses, but from a shift in interests. The day resembling everyone else stops selling, the briefs will change. The signals from quiet luxury and from public fatigue suggest that point is no longer far off.

Common questions

See also